Abstract
Molecular Pathology (MP) is at the heart of modern diagnostics and translational research, but the controversy on how MP is best developed has not abated. The lack of a proper model or trained pathologists to support the diagnostic and research missions makes MP a rare commodity overall. Here we analyse the scientific and technology areas, in research and diagnostics, which are encompassed by MP of solid tumours; we highlight the broad overlap of technologies and analytical capabilities in tissue research and diagnostics; and we describe an integrated model that rationalizes technical know-how and pathology talent for both. The model is based on a single, accredited laboratory providing a single standard of high-quality for biomarker discovery, biomarker validation and molecular diagnostics.
Original language | English |
---|---|
Pages (from-to) | 1163-8 |
Number of pages | 6 |
Journal | Molecular oncology |
Volume | 8 |
Issue number | 7 |
Early online date | 12 Aug 2014 |
DOIs | |
Publication status | Published - 07 Oct 2014 |